No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
6-K: Report of foreign private issuer (related to financial reporting)
Genmab A/S Share Capital Reduction
Genmab Analyst Ratings
H.C. Wainwright Maintains Genmab(GMAB.US) With Buy Rating, Cuts Target Price to $37
Express News | Genmab : H.c. Wainwright Cuts Target Price to $37 From $50
Genmab's Strong Financial Performance and Strategic Positioning Justify Buy Rating Despite Minor Setbacks